Clear cell meningiomas are rare meningioma variants and are recognized as World Health Organization grade II tumours. They may be difficult to manage given their propensity to recur early especially if present in surgically challenging locations. We describe a rare case of a fourth ventricular clear cell meningioma without dural attachment in a 14-year-old boy with an unusual presentation of failure to thrive. The case is presented in detail and a review of the recent literature is discussed.

1.
Gao X, Zhang R, Mao Y, Wang Y: Childhood and juvenile meningiomas. Childs Nerv Syst 2009;25:1571–1580.
2.
Miranda P, Simal JA, Vila M, Hernández M, Menor F, Álvarez-Garijo JA: Posterior fossa clear cell meningioma without dural attachment in a child. Childs Nerv Syst 2009;25:389–392.
3.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007;114:97–109.
4.
Ma L, Liu W, Wang K, Shrestha B, Zhang Y: Intracranial clear-cell meningioma. Acta Neurochir 2009;151:373–378.
5.
Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, Sharma BS, Mahapatra AK: Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases. J Neurooncol 2007;81:315–321.
6.
Oviedo A, Pang D, Zovickian J, Smith M: Clear cell meningioma: case report and review of the literature. Pediatr Dev Pathol 2005;8:386–390.
7.
Teo JG, Goh KY, Rosenblum MK, Muszynski CA, Epstein FJ: Intraparenchymal clear cell meningioma of the brainstem in a 2-year- old child. Case report and literature review. Pediatr Neurosurg 1998;28:27–30.
8.
Carlotti CG Jr, Neder L, Colli BO, Dos Santos MB, Garcia AS, Elias J Jr, Chimelli LC: Clear cell meningioma of the fourth ventricle. Am J Surg Pathol 2003;27:131–135.
9.
Yu KB, Lim MK, Kim HJ, Suh CH, Park HC, Kim EY, Han HS: Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle. Korean J Radiol 2002;3:125–129.
10.
Sato T, Sugiyama T, Kawataki T, Sato E, Horikoshi T, Sugita K, Kinouchi H: Clear cell meningioma causing Castleman syndrome in a child: case report. J Neurosurg Pediatr 2010;5:622–625.
11.
Traunecker H, Mallucci C, Grundy R, Pizer B, Saran F: Children’s Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people. Br J Neurosurg 2008;22:13–25.
12.
Ahn ES, Chin LS, Gyure KA, Hudes RS, Ragheb J, Di Patri AJ Jr: Long-term control after resection and gamma knife surgery of an intracranial clear cell meningioma: case report. J Neurosurg Pediatr 2005;102(3 suppl):303–306.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.